Berkeley Lights to Participate in the Stifel 2021 Virtual Healthcare Conference

Rhea-AI Summary

Berkeley Lights, Inc. (Nasdaq: BLI) announced its participation in the Stifel 2021 Virtual Healthcare Conference, scheduled for November 16 at 1:00 p.m. PT / 4:00 p.m. ET. The company will engage in a fireside chat, which can be accessed through a live and archived webcast on their website. Berkeley Lights is known for its innovative digital cell biology solutions that accelerate biotherapeutic development. Their platform provides critical data on single cells, enhancing research capabilities in cell-based products.

EMERYVILLE, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the company will be participating in the upcoming Stifel 2021 Virtual Healthcare Conference.

Berkeley Lights’ management is scheduled to participate in a fireside chat on Tuesday, November 16 at 1:00 p.m. Pacific Time / 4:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.berkeleylights.com.

About Berkeley Lights 
Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain. 

Berkeley Lights’ Beacon^® and Lightning™ systems and Culture Station™ instrument are FOR RESEARCH USE ONLY.  Not for use in diagnostic procedures. 

Forward-Looking Statements
To the extent that statements contained in this press release are not descriptions of historical facts regarding Berkeley Lights or its products, they are forward-looking statements reflecting the current beliefs and expectations of management. Such forward-looking statements involve substantial known and unknown risks and uncertainties that relate to future events, and actual results and product performance could differ significantly from those expressed or implied by the forward-looking statements. Berkeley Lights undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties relating to the Company’s growth and continual evolution see the statements in the "Risk Factors" sections, and elsewhere, in our filings with the U.S. Securities and Exchange Commission.

Media Contact 
Media@berkeleylights.com

Investor Contact 
IR@berkeleylights.com

FAQ

When will Berkeley Lights participate in the Stifel 2021 Virtual Healthcare Conference?

Berkeley Lights will participate in the conference on November 16, 2021, at 1:00 p.m. PT / 4:00 p.m. ET.

How can I access the Berkeley Lights presentation at the healthcare conference?

You can access the live and archived webcast of the Berkeley Lights presentation on their website under the 'Investors' section.

What is the focus of Berkeley Lights as a company?

Berkeley Lights focuses on digital cell biology, enabling the rapid development and commercialization of biotherapeutics and cell-based products.

What products does Berkeley Lights offer?

Berkeley Lights offers the Beacon® and Lightning™ systems as part of their digital cell biology platform.

What is the stock symbol for Berkeley Lights?

The stock symbol for Berkeley Lights is BLI.